Colchicine, a compound derived from the dried seeds of the meadow saffron, has long been used to treat gout and is part of an FDA-approved combination product but it had not been approved by the FDA as a standalone drug as reported by Cole Petrochko, Staff Writer, MedPage Today. In common use for almost 200 years, colchicine (Colcrys) has won FDA approval for treatment of acute flares of gout and familial Mediterranean fever. Read more>
From Wikimedia:
Colchicine is a toxic natural product and secondary metabolite, originally extracted from plants of the genus Colchicum (Autumn crocus, Colchicum autumnale, also known as "Meadow saffron"). It was used originally to treat rheumatic complaints, especially gout, and still finds use for these purposes today. It was also prescribed for its cathartic and emetic effects. Colchicine's present medicinal use is in the treatment of gout and familial Mediterranean fever; it can also be used as initial treatment for pericarditis and preventing recurrences of the condition. It is also being investigated for its use as an anti-cancer drug. In neurons, axoplasmic transport is disrupted by colchicine. Read more from Wikipedia>
Caution: Consult family physician before starting any medical drug regime.
No comments:
Post a Comment